Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of trabectedin for the
treatment of localized (non-metastatic) myxoid / round cell liposarcoma (malignant tumor
derived from primitive or embryonal lipoblastic cells).
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.